These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 28485470)

  • 21. Sinonasal aspergillosis: Outcome after topical treatment in dogs with cribriform plate lysis.
    Belda B; Petrovitch N; Mathews KG
    J Vet Intern Med; 2018 Jul; 32(4):1353-1358. PubMed ID: 29957889
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical resolution of nasal aspergillosis following therapy with a homeopathic remedy in a dog.
    Epstein S; Hardy R
    J Am Anim Hosp Assoc; 2011; 47(6):e110-5. PubMed ID: 22058356
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Posaconazole treatment of refractory coccidioidomycosis in dogs.
    Shubitz LF; Schlacks S; Vishkautsan P; Butkiewicz CD; Worthing KA
    J Vet Intern Med; 2021 Nov; 35(6):2772-2777. PubMed ID: 34658074
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel antifungal agents as salvage therapy for invasive aspergillosis in patients with hematologic malignancies: posaconazole compared with high-dose lipid formulations of amphotericin B alone or in combination with caspofungin.
    Raad II; Hanna HA; Boktour M; Jiang Y; Torres HA; Afif C; Kontoyiannis DP; Hachem RY
    Leukemia; 2008 Mar; 22(3):496-503. PubMed ID: 18094720
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Caspofungin plus posaconazole as salvage therapy of invasive fungal infections in immunocompromised patients.
    Lellek H; Waldenmaier D; Dahlke J; Ayuk FA; Wolschke C; Kröger N; Zander AR
    Mycoses; 2011 Jan; 54 Suppl 1():39-44. PubMed ID: 21126271
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of canine nasal aspergillosis with a new non-invasive technique. Failure with enilconazole.
    Bray JP; White RA; Lascelles BD
    J Small Anim Pract; 1998 May; 39(5):223-6. PubMed ID: 9631356
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics of orally administered terbinafine in African penguins (Spheniscus demersus) for potential treatment of aspergillosis.
    Bechert U; Christensen JM; Poppenga R; Le H; Wyatt J; Schmitt T
    J Zoo Wildl Med; 2010 Jun; 41(2):263-74. PubMed ID: 20597218
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Update on canine sinonasal aspergillosis.
    Peeters D; Clercx C
    Vet Clin North Am Small Anim Pract; 2007 Sep; 37(5):901-16, vi. PubMed ID: 17693205
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Keratomycosis in a pet rabbit (Oryctolagus cuniculus) treated with topical 1% terbinafine ointment.
    Bourguet A; Guyonnet A; Donzel E; Guillot J; Pignon C; Chahory S
    Vet Ophthalmol; 2016 Nov; 19(6):504-509. PubMed ID: 26632085
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Repeated rhinoscopic and serologic assessment of the effectiveness of intranasally administered clotrimazole for the treatment of nasal aspergillosis in dogs.
    Pomrantz JS; Johnson LR
    J Am Vet Med Assoc; 2010 Apr; 236(7):757-62. PubMed ID: 20367042
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Canine nasal aspergillosis.
    Benitah N
    Clin Tech Small Anim Pract; 2006 May; 21(2):82-8. PubMed ID: 16711614
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term survival of four dogs with disseminated Aspergillus terreus infection treated with itraconazole.
    Kelly SE; Shaw SE; Clark WT
    Aust Vet J; 1995 Aug; 72(8):311-3. PubMed ID: 8579564
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aspergillosis in pet animals and treatment of experimental infection in laboratory animals.
    van Cutsem J
    Tijdschr Diergeneeskd; 1991 Apr; 116 Suppl 1():38S-39S. PubMed ID: 2048073
    [No Abstract]   [Full Text] [Related]  

  • 34. Azole resistance in canine and feline isolates of Aspergillus fumigatus.
    Talbot JJ; Kidd SE; Martin P; Beatty JA; Barrs VR
    Comp Immunol Microbiol Infect Dis; 2015 Oct; 42():37-41. PubMed ID: 26387063
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of canine nasal aspergillosis with enilconazole.
    Sharp NJ; Sullivan M; Harvey CE; Webb T
    J Vet Intern Med; 1993; 7(1):40-3. PubMed ID: 8455182
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnostic value of MRI in dogs with inflammatory nasal disease.
    Furtado AR; Caine A; Herrtage ME
    J Small Anim Pract; 2014 Jul; 55(7):359-63. PubMed ID: 24754308
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of two minimally invasive enilconazole perendoscopic infusion protocols for the treatment of canine sinonasal aspergillosis.
    Vangrinsven E; Girod M; Goossens D; Desquilbet L; Clercx C; Billen F
    J Small Anim Pract; 2018 Dec; 59(12):777-782. PubMed ID: 30362215
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Posaconazole as salvage therapy in patients with invasive fungal infections after solid organ transplant.
    Alexander BD; Perfect JR; Daly JS; Restrepo A; Tobón AM; Patino H; Hardalo CJ; Graybill JR
    Transplantation; 2008 Sep; 86(6):791-6. PubMed ID: 18813103
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oral administration of voriconazole with surgical fungal plaque debridement for the treatment of sinonasal aspergillosis with cribriform plate lysis in three dogs.
    Bray RN; Raghu CL; Leuin AS; Barry-Heffernan CA; Pritchard JC
    J Am Vet Med Assoc; 2020 Jan; 256(1):111-116. PubMed ID: 31841098
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Posaconazole: an extended-spectrum triazole antifungal agent.
    Schiller DS; Fung HB
    Clin Ther; 2007 Sep; 29(9):1862-86. PubMed ID: 18035188
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.